Is ACAD or ELVN more profitable?

ACAD runs the higher net margin — ACAD at 33.42% versus ELVN at 0.00%.

How have ACAD and ELVN total returns compared?

Over the past 5 years, ACAD delivered 3.52% and ELVN delivered 24.57% annualized total return. Past performance doesn't predict future results.

Acadia Pharmaceuticals Inc. (ACAD) vs Enliven Therapeutics, Inc. (ELVN)

A side-by-side comparison of Acadia Pharmaceuticals Inc. and Enliven Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACAD

Acadia Pharmaceuticals Inc.

$3.44B

$20.09HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

ELVN

Enliven Therapeutics, Inc.

$3.09B

$43.23HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — ACAD vs ELVN

growth of $100 · dividends reinvested · last 7y

ACAD -51.0% (-9.7%/yr)ELVN -24.2% (-3.9%/yr)ELVN compounded faster over this window

ACAD ELVN

ACAD vs ELVN: by the numbers

•ACAD is the larger company ($3.44B vs $3.09B market cap).
•ACAD is profitable (33.42% net margin) while ELVN runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	ACAD	ELVN
P/E ratio	9.05	N/A
Forward P/E	32.61	N/A
P/S ratio	3.02	N/A
P/B ratio	2.63	3.45
EV / EBITDA	31.79	N/A
FCF yield	5.07%	N/A

Profitability

Metric	ACAD	ELVN
Gross margin	91.13%	0.00%
Operating margin	7.59%	0.00%
Net margin	33.42%	0.00%
ROE	29.12%	-11.83%
ROIC	6.25%	-13.88%

Growth (annualized)

Metric	ACAD	ELVN
Revenue CAGR (5Y)	19.70%	N/A
Total return CAGR (5Y)	3.52%	24.57%

Frequently asked

Is ACAD or ELVN more profitable?: ACAD runs the higher net margin — ACAD at 33.42% versus ELVN at 0.00%.
How have ACAD and ELVN total returns compared?: Over the past 5 years, ACAD delivered 3.52% and ELVN delivered 24.57% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACAD analysis Full ELVN analysis Interactive comparison tool

Dig into the metrics

Acadia Pharmaceuticals P/E ratio Acadia Pharmaceuticals ROE Enliven Therapeutics ROE Acadia Pharmaceuticals operating margin Enliven Therapeutics operating margin Acadia Pharmaceuticals revenue growth Enliven Therapeutics revenue growth Acadia Pharmaceuticals free cash flow Enliven Therapeutics free cash flow

Acadia Pharmaceuticals & Enliven Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.